Matrix metalloproteinase-2 is associated with tenascin-C in calcific aortic stenosis

American Journal of Pathology

Volumn 159, Issue 1, 2001, Pages 321-327

  Jian, Bo ^a   Jones, Peter L ^a   Li, Quanyi ^a   Mohler III, Emile R ^b   Schoen, Frederick J ^c   Levy, Robert J ^a  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; TENASCIN;

ANIMAL; AORTA VALVE; AORTA VALVE STENOSIS; ARTICLE; CALCINOSIS; CELL CULTURE; FEMALE; GENE EXPRESSION; GENETICS; METABOLISM; PHYSIOLOGY; SHEEP; UPREGULATION;

ANIMALS; AORTIC VALVE; AORTIC VALVE STENOSIS; CALCINOSIS; CELLS, CULTURED; FEMALE; GENE EXPRESSION; MATRIX METALLOPROTEINASE 2; SHEEP; TENASCIN; UP-REGULATION;

EID: 0035408476     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)61698-7     Document Type: Article

References (33)

1. Kim KM: Calcification of matrix vesicles in human aortic valve and aortic media. Fed Proc 1976, 35:156-162
2. Kim KM: Apoptosis and calcification. Scanning Microsc 1995, 9:1137-1178
3. Srivatsa SS, Harrity PJ, Maercklein PB, Kleppe L, Veinot J, Edwards WD, Johnson CM, Fitzpatrick LA: Increased cellular expression of matrix proteins that regulate mineralization is associated with calcification of native human and porcine xenograft bioprosthetic heart valves. J Clin Invest 1997, 99:996-1009
4. Bini A, Mann KG, Kudryk BJ, Schoen FJ: Noncollagenous bone matrix proteins, calcification, and thrombosis in carotid artery atherosclerosis. Arterioscler Thromb Vasc Biol 1999, 19:1852-1861
5. Mori K, Shioi A, Jono S, Nishizawa Y, Morii H: Expression of matrix Gla protein (MGP) in an in vitro model of vascular calcification. FEBS Lett 1998, 433:19-22
6. O'Brien KD, Kuusisto J, Reichenbacn DD, Ferguson M, Giachelli C, Alpers CE, Otto CM: Osteopontin is expressed in human aortic valvular lesions. Circulation 1995, 92:2163-2168
7. Bostrom K, Watson KE, Horn S, Wortham C, Herman IM, Demer LL: Bone morphogenetic protein expression in human atherosclerotic lesions. J Clin Invest 1993, 91:1800-1809
8. Loftus IM, Naylor AR, Goodall S, Crowther M, Jones L, Bell PR, Thompson MM: Increased matrix metalloproteinase-9 activity in unstable carotid plaques: a potential role in acute plaque disruption. Stroke 2000, 31:40-47
9. Mohler III ER, Adam LP, McClelland P, Graham L, Hathaway DR: Detection of osteopontin in calcified human aortic valves. Arterioscler Thromb Vasc Biol 1997, 17:547-552
10. Mohler III ER, Chawla MK, Chang AW, Vyavahare N, Levy RJ, Graham L, Gannon FH: Identification and characterization of calcifying valve cells from human and canine aortic valves. J Heart Valve Dis 1999, 8:254-260
11. Mackie E: Molecules in focus: tenascin-C. Int J Biochem Cell Biol 1997, 29:1133-1137
12. Mackie E, Murphy L: The role of tenascin-C and related glycoproteins in early chondrogenesis. Microsc Res Tech 1998, 43:102-110
13. Hurle JM, Garcia-Martinez V, Ros MA: Immunofluorescent localization of tenascin during the morphogenesis of the outflow tract of the chick embryo heart. Anat Embryol 1990, 181:149-155
14. Wallner K, Li C, Shah PK, Fishbein MC, Forrester JS, Kaul S, Sharifi BG: Tenascin-C is expressed in macrophage-rich human coronary atherosclerotic plaque. Circulation 1999, 99:1284-1289
15. Simionescu D, Simionescu A, Deac R: Detection of remnant proteolytic activities in unimplanted glutaraldehyde treated bovine pericardium and explanted bioprotheses. J Biomed Mater Res 1993, 27: 821-829
16. Talhouk R, Chin JR, Unemori EN, Werb Z, Bissell MJ: Proteinases of the mammary gland: developmental regulation in vivo and vectorial secretion in culture. Development 1991, 112:439-449
17. Cowan K, Jones P, Rabinovitch M: Matrix metalloproteinase activity coincides with deposition of tenascin rich foci, colocalizing with proliferation in porcine pulmonary artery organ culture. Circulation 1997 (Suppl I):243
18. Jones PL, Jones FS, Zhou B, Rabinovitch M: Induction of vascular smooth muscle cell tenascin-C gene expression by denatured type I collagen is dependent upon a β3 integrin-mediated mitogen-activated protein kinase pathway and a 122-base pair promoter element. J Cell Sci 1999, 112:435-445
19. Tremble P, Chiquet-Ehrismann R, Werb Z: The extracellular matrix ligands fibronectin and tenascin collaborate in regulating collagenase gene expression in fibroblasts. Mol Biol Cell 1994, 5:439-453
20. Edep ME, Shirani J, Wolf P, Brown DL: Matrix metalloproteinase expression in nonrheumatic aortic stenosis. Cardiovasc Pathol 2000, 9:281-286
21. Jones P, Crack J, Rabinovitch M: Regulation of tenascin-C, a vascular smooth muscle cell survival factor that interacts with the α ν β-3 intergrin to promote epidermal growth factor receptor phosphorylation and growth. J Cell Biol 1997, 139:279-293
22. Erickson HP, Bourdon MA: Tenascin: an extracellular matrix protein prominent in specialized embryonic tissues and tumors. Annu Rev Cell Biol 1989, 5:71-92
23. Jones P, Cowan K, Rabinovitch M: Tenascin-C, proliferation and subendothelial fibronectin in progressive pulmonary vascular disease. Am J Pathol 1997, 150:1349-1360
24. Balica M, Bostrom K, Shin V, Tillisch K, Demer LL: Calcifying subpopulation of bovine aortic smooth muscle cells is responsive to 17β-estradiol. Circulation 1997, 95:1954-1960
25. Sumida A, Fukuen S, Yamamoto I, Matsuda H, Naohara M, Azuma J: Quantitative analysis of constitutive and inducible CYPs mRNA expression in the HepG2 cell line using reverse transcription-competitive PCR. Biochem Biophys Res Commun 2000, 267:756-760
26. Connolly JM, Rose DP: Expression of the invasive phenotype by MCF-7 human breast cancer cells transfected to overexpression protein kinase C-a or the erbB2 proto-oncogene. Int J Oncol 1997, 10:71-76
27. Mackie EJ, Ramsey S: Modulation of osteoblast behavior by tenascin. J Cell Sci 1996, 109:1597-1604
28. Smith GM, Hale JH: Macrophage/Microglia regulation of astrocytic tenascin: synergistic action of transforming growth factor-β and basic fibroblast growth factor. J Neurosci 1997, 17:9624-9633
29. Latijnhouwers MA, Pfundt R, de Jongh GJ, Schalkwijk J Tenascin-C expression in human epidermal keratinocytes is regulated by inflammatory cytokines and a stress response pathway. Matrix Biol 1998, 17:305-316
30. Jo Y, Yeon J, Kim HJ, Lee ST: Analysis of tissue inhibitor of metalloproteinases-2 effect on pro-matrix metalloproteinase-2 activation by membrane-type 1 matrix metalloproteinase using baculovirus/insect-cell expression system. Biochem J 2000, 345:511-519
31. Anderson HC: Mechanism of mineral formation in bone. Lab Invest 1989, 60:320-330
32. Wu LN, Sauer GR, Genge BR, Wuthier RE: Induction of mineral deposition by primary cultures of chicken growth plate chondrocytes in ascorbate-containing media: evidence of an association between matrix vesicles and collagen. J Biol Chem 1989, 264: 21346-21355
33. Schoen FJ, Levy RJ: Bioprosthetic heart valve calcification: membrane-mediated events and alkaline phosphatase. Bone Miner 1992, 17:129-133